MED Quote, Financials, Valuation and Earnings

Eventiko, Inc. has a net margin of -2.53% compared to Medifast, Inc.'s net margin of --. Medifast, Inc.'s return on equity of 0.12% beat Eventiko, Inc.'s return on equity of --.

Medifast, Inc. has a consensus price target of $15.00, signalling upside risk potential of 31.35%. On the other hand Eventiko, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Medifast, Inc. has higher upside potential than Eventiko, Inc., analysts believe Medifast, Inc. is more attractive than Eventiko, Inc..

Medifast, Inc. has a beta of 0.480, which suggesting that the stock is 51.955% less volatile than S&P 500. In comparison Eventiko, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. Eventiko, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. Eventiko, Inc. pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $89.4M, which are larger than Eventiko, Inc. quarterly revenues of --. Medifast, Inc.'s net income of -$2.3M is lower than Eventiko, Inc.'s net income of -$4.3K. Notably, Medifast, Inc.'s price-to-earnings ratio is 546.41x while Eventiko, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.29x versus -- for Eventiko, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Frontdoor, Inc. has a net margin of -2.53% compared to Medifast, Inc.'s net margin of 17.15%. Medifast, Inc.'s return on equity of 0.12% beat Frontdoor, Inc.'s return on equity of 103.71%.

Medifast, Inc. has a consensus price target of $15.00, signalling upside risk potential of 31.35%. On the other hand Frontdoor, Inc. has an analysts' consensus of $59.33 which suggests that it could fall by -3.15%. Given that Medifast, Inc. has higher upside potential than Frontdoor, Inc., analysts believe Medifast, Inc. is more attractive than Frontdoor, Inc..

Medifast, Inc. has a beta of 0.480, which suggesting that the stock is 51.955% less volatile than S&P 500. In comparison Frontdoor, Inc. has a beta of 1.311, suggesting its more volatile than the S&P 500 by 31.125%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. Frontdoor, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. Frontdoor, Inc. pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $89.4M, which are smaller than Frontdoor, Inc. quarterly revenues of $618M. Medifast, Inc.'s net income of -$2.3M is lower than Frontdoor, Inc.'s net income of $106M. Notably, Medifast, Inc.'s price-to-earnings ratio is 546.41x while Frontdoor, Inc.'s PE ratio is 17.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.29x versus 2.25x for Frontdoor, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Interactive Strength, Inc. has a net margin of -2.53% compared to Medifast, Inc.'s net margin of -108.64%. Medifast, Inc.'s return on equity of 0.12% beat Interactive Strength, Inc.'s return on equity of -163.73%.

Medifast, Inc. has a consensus price target of $15.00, signalling upside risk potential of 31.35%. On the other hand Interactive Strength, Inc. has an analysts' consensus of $8.50 which suggests that it could grow by 745.77%. Given that Interactive Strength, Inc. has higher upside potential than Medifast, Inc., analysts believe Interactive Strength, Inc. is more attractive than Medifast, Inc..

Medifast, Inc. has a beta of 0.480, which suggesting that the stock is 51.955% less volatile than S&P 500. In comparison Interactive Strength, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. Interactive Strength, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. Interactive Strength, Inc. pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $89.4M, which are larger than Interactive Strength, Inc. quarterly revenues of $4.8M. Medifast, Inc.'s net income of -$2.3M is higher than Interactive Strength, Inc.'s net income of -$5.2M. Notably, Medifast, Inc.'s price-to-earnings ratio is 546.41x while Interactive Strength, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.29x versus 0.08x for Interactive Strength, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

WW International has a net margin of -2.53% compared to Medifast, Inc.'s net margin of -38.91%. Medifast, Inc.'s return on equity of 0.12% beat WW International's return on equity of --.

Medifast, Inc. has a consensus price target of $15.00, signalling upside risk potential of 31.35%. On the other hand WW International has an analysts' consensus of $1.10 which suggests that it could grow by 340.71%. Given that WW International has higher upside potential than Medifast, Inc., analysts believe WW International is more attractive than Medifast, Inc..

Medifast, Inc. has a beta of 0.480, which suggesting that the stock is 51.955% less volatile than S&P 500. In comparison WW International has a beta of 1.298, suggesting its more volatile than the S&P 500 by 29.755%.

Medifast, Inc. has a quarterly dividend of $1.65 per share corresponding to a yield of 0%. WW International offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medifast, Inc. pays -- of its earnings as a dividend. WW International pays out -- of its earnings as a dividend.

Medifast, Inc. quarterly revenues are $89.4M, which are smaller than WW International quarterly revenues of $186.6M. Medifast, Inc.'s net income of -$2.3M is higher than WW International's net income of -$72.6M. Notably, Medifast, Inc.'s price-to-earnings ratio is 546.41x while WW International's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medifast, Inc. is 0.29x versus 0.03x for WW International. Usually stocks with elevated PS ratios are considered overvalued.